Study on key outcome indexes in treatment of migraine with acupuncture and moxibustion.
10.13703/j.0255-2930.20220129-k0002
- Author:
Shuo CUI
1
;
Xiao-Yu WANG
1
;
Ya-Ping LIU
1
;
Jing HU
1
;
Zhong-Jie CHEN
1
;
Jin HUO
1
;
Qi GAO
1
;
Shu-Hua MA
2
;
Jing-Jing WANG
1
Author Information
1. Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
2. Experimental Research Center, China Academy of Chinese Medical Sciences.
- Publication Type:Journal Article
- Keywords:
acupuncture and moxibustion;
attack stage treatment;
migraine;
outcome index;
prophylactic treatment
- MeSH:
Humans;
Quality of Life;
Headache/therapy*
- From:
Chinese Acupuncture & Moxibustion
2022;42(12):1413-1420
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To identify the key outcome indexes in treatment of migraine with acupuncture and moxibustion.
METHODS:Using literature research, questionnaire survey and consensus conference, the key outcome indexes in treatment of migraine with acupuncture and moxibustion were screened and prioritized.
RESULTS:The critical outcome indexes for the treatment in attack stage of migraine included 6 effectiveness outcome indexes (headache intensity, headache duration, headache relieve time, effectiveness and level of headache relief within 2 h, headache-related quality of life, level of headache relief within 24 h) and 1 safety outcome index (incidence of serious adverse reactions). The critical outcome indexes for prophylactic treatment included 6 effectiveness outcome indexes (headache day, headache frequency, headache intensity, effective rate, headache-related quality of life, health-related quality of life) and 1 safety outcome index (incidence of serious adverse reactions).
CONCLUSION:In terms of the attack stage treatment and prophylactic treatment with acupuncture and moxibustion, the outcome indexes are different, among which, those can directly reflect the conditions of migraine should be optioned in priority. To assess the effectiveness of attack stage, the headache intensity is preferred, using the visual analogue scale (VAS) score, and the preferred time is 2 hours after treatment. Regarding the effectiveness of prophylactic treatment, the headache day, headache frequency and headache intensity should be firstly considered in the assessment, in which, the preferred time for assessment is 12 weeks into treatment, while, the best time for follow-up should be 12 weeks after treatment completion. When the quality of life is considered, the migraine-specific quality of life questionnaire (MSQ) is the top option. For either the attack stage treatment or the prophylactic treatment, the high attention should be laid on the outcome indexes for safety and medical economics evaluation.
